SyntekaBio Inc (226330) — Financial Flexibility Index
SyntekaBio Inc (226330) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of ₩-1.98 Billion (operating CF ₩-2.01 Billion minus capex ₩30.01 Million) represents 0% of total liabilities (₩21.59 Billion). Also explore SyntekaBio Inc (226330) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SyntekaBio Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for SyntekaBio Inc across 8 annual periods. Check SyntekaBio Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for SyntekaBio Inc (2017–2024)
Year-by-year free cash flow to debt coverage for SyntekaBio Inc. For the full company profile including market capitalisation, see how much is SyntekaBio Inc worth.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.25x | ₩-4.69 Billion | ₩-10.51 Billion | ₩18.77 Billion | ▼ -501.1% |
| 2023 | 0.06x | ₩1.35 Billion | ₩-8.08 Billion | ₩21.69 Billion | ▲ +514.1% |
| 2022 | 0.01x | ₩245.87 Million | ₩-8.51 Billion | ₩24.23 Billion | ▼ -71.6% |
| 2021 | 0.04x | ₩1.44 Billion | ₩-6.04 Billion | ₩40.25 Billion | ▲ +103.0% |
| 2020 | -1.20x | ₩-3.88 Billion | ₩-4.67 Billion | ₩3.24 Billion | ▲ +9.9% |
| 2019 | -1.33x | ₩-2.44 Billion | ₩-3.28 Billion | ₩1.84 Billion | ▼ -711.2% |
| 2018 | -0.16x | ₩-1.71 Billion | ₩-2.37 Billion | ₩10.47 Billion | ▲ +64.2% |
| 2017 | -0.46x | ₩-2.42 Billion | ₩-2.49 Billion | ₩5.29 Billion | — |